Astria Therapeutics's total assets for Q4 2024 were $342.36M, a decrease of -5.33% from the previous quarter. ATXS total liabilities were $23.10M for the fiscal quarter, a 15.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.